Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06270680Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by The Pennsylvania State University. Primary endpoints: Blood and saliva biomarkers at 16 weeks, Speed of visual processing at 16 weeks and 5 more. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06270680.